Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes

Nephrology

Volumn 9, Issue 1, 2004, Pages 26-30

  Nakamura, Ikuko ^a   Iwase, Hitoo ^a,e   Arai, Kenji ^b   Nagai, Yoko ^b   Toma, Kazunori ^c   Katsumata, Tadashi ^a   Hiki, Yoshiyuki ^d   Kokubo, Tohru ^a   Sano, Takashi ^a   Kobayashi, Yutaka ^a  

^a KITASATO UNIVERSITY   (Japan)

^b ASAHI KASEI CORPORATION   (Japan)

^c NOGUCHI INSTITUTE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody against hinge peptide; Autoantibody; Gender difference; Immunoglobulin A nephropathy; Synthetic glycopeptide

Indexed keywords

EPITOPE; GLYCOPEPTIDE; HINGE GLYCOPEPTIDE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SEX DIFFERENCE; STRUCTURE ANALYSIS;

ANTIGEN-ANTIBODY REACTIONS; EPITOPES; FEMALE; GLOMERULONEPHRITIS, IGA; GLYCOPEPTIDES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; PEPTIDES; SEX CHARACTERISTICS;

EID: 10744225820     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2003.00225.x     Document Type: Article

References (33)

1. Baenziger J, Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide unit. J. Biol. Chem. 1974; 249: 7260-9.
2. Baenziger J, Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J. Biol Chem. 1974; 249: 7270-81.
3. Mattu TS, Pleass RJ, Willis AC et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc α receptor interactions. J. Biol. Chem. 1998; 273: 2260-72.
4. Iwase H, Ishii-Karakasa I, Fujii E, Hotta K, Hiki Y, Kobayashi Y. Analysis of glycoform of O-glycan from human myeloma immunoglobulin A1 by gas-phase hydrazinolysis following pyridylamination of oligosaccharides. Anal. Biochem. 1992; 206: 202-5.
5. Iwase H, Tanaka A, Hiki Y et al. Abundance of Galβ1,3GalNAc in O-linked oligosaccharide on hinge region of polymerized IgA1 and heat-aggregated IgA1 from normal human serum. J. Biochem. 1996; 120: 92-7.
6. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J. Am. Soc. Nephrol 1998; 9: 2048-54.
7. Iwase H, Tanaka A, Hiki Y et al. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide. J. Biochem. 1996; 120: 393-7.
8. Iwase H, Tanaka A, Hiki Y et al. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J. Chromatogr. B. 1999; 724: 1-7.
9. Iwase H, Ohkawa S, Ishii-Karakasa I et al. Study of the relationship between sticky human serum IgA1 and its O-glycan glycoform. Biochem. Biophys. Res. Commun. 1999; 261: 472-7.
10. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J. Clin. Invest. 1980; 66: 1432-6.
11. Glassock RJ. Where do we go from here? Am. J. Kidney Dis. 1988; 12: 449-52.
12. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J. Clin. Lab. Anal. 1990; 4: 115-19.
13. Allen AC, Harper SS. Galactosylation of N-and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 1995; 100: 470-4.
14. Allen AC, Topham PS, Harper SJ, Feehally J. Leukocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol. Dial. Transplant. 1997; 12: 701-6.
15. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients in present in complex with IgG. Kidney Int. 1997; 52: 509-16.
16. Hiki Y, Iwase H, Kokubo T et al. Association of asialogalactosylβ1- 3N-acetylgalactosamine on the hinge with a conformational instability of jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J. Am. Soc. Nephrol. 1996; 7: 955-60.
17. Hiki Y, Iwase H, Saitoh M et al. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron 1996; 74: 429-35.
18. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgAl hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J. Am. Soc. Nephrol. 1997; 8: 915-19.
19. Iwase H, Hiki Y, Hotta K. O-Linked oligosaccharides in the hinge region of immunoglobulin Al and their involvement in IgA nephropathy. Trends Glycosci. Glycotechnol. 1998; 10: 13-22.
20. Hiki Y, Tanaka A, Kokubo T et al. Analysis of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. J. Am. Soc. Nephrol. 1998; 9: 577-82.
21. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycan in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 1999; 10: 1763-71.
22. Iwase H, Yokozeki Y, Hiki Y et al. Human serum immunoglobulin G3 subclass bound preferentially to asialo-,agalacto immunoglobulin A1/Sepharose. Biochem. Biophys. Res. Commun. 1999; 264: 424-9.
23. Odani H, Hiki Y, Takahashi M et al. Direct evidence for decreased sialylation and galactosylation of human serum IgAI Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem. Biophys. Res. Commun. 2000; 271: 268-74.
24. Hiki Y, Kokubo T, Iwase H et al. Under-glycosylation of IgAI hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 1999; 10: 760-9.
25. Hiki Y, Odani M, Takahashi M et al. Mass spectrometry proves under-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001; 59: 1077-85.
26. Sano T, Hiki Y, Kokubo T, Iwase H, Endo H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol. Dial. Transplant. 2002; 17: 50-6.
27. Kokubo T, Hiki Y, Iwase H et al. Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Tranplant. 1999; 14: 81-5.
28. Kokubo T, Hashizume K, Iwase H et al. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 2000; 15: 28-33.
29. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and anti glycan antibodies. J. Clin. Invest. 1999; 104: 73-81.
30. Ibels LS, Gyory AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102.
31. D'Amico G. Epidemiological, clinical and prognostic indices in IgA nephropathy. Nephrology 1997; 3: 13-17.
32. Mera J, Uchida S, Nagase M. Clinicopathologic study on prognostic markers in IgA nephropathy. Nephron 2000; 84: 148-57.
33. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am. J. Kidney Dis. 2001; 38: 728-35.